Please login to the form below

Not currently logged in
Email:
Password:

Jutta Heim joins Nuevolution

Takes role as director and scientific advisor at Danish discovery company

Nuevolution Jutta HeimNuevolution has appointed Prof Dr Jutta Heim as director and senior scientific advisor to its board of directors.

She brings to the Copenhagen-based small molecule lead discovery company more than 20 years of experiences working for Ciba-Geigy/Novartis.   

She was involved in the development and launch of anti-thrombotic and fibrinolytic products and established Novartis' oncology molecular genetics department.  

Prof Heim served as Novartis' senior scientific expert in molecular biology, was a member of its research management board and finished her time with the company heading the Novartis Lead Discovery Center with worldwide responsibility.  

She has also served as CSO at Swiss biopharma company Basilea Pharmaceutica, which focuses on anti-infectives, inflammation and oncology.  

Most recently Prof Heim was chief technology officer and chief scientific officer at health, wellness and nutrition company Evolva, 2009 to 2013.  

Alex Gouliaev, Nuevolution CEO, said: “Jutta's significant expertise and input has already been well appreciated by management and our board. We are certain that her experience from the industry, broad insight into general drug discovery and, in particular, within oncology will add significant value to the company.”

28th August 2013

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

BRIC markets
BRIC markets
Why these countries offer an opportunity for pharma despite a slowdown...
Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story
Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club....
Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...

Infographics